There were no significant differences in relative DNMT1 expression between early stage BA patients (non-jaundice, mild fibrosis, and low AST value) and advanced BA patients (jaundice, severe fibrosis, and high AST value) (P>0.05). This evidence concerns the gene DNMT1 and breast angiosarcoma.